Cardiol Therapeutics Inc. (CRDL)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.30
0.01 (0.78%)
At close: Jan 28, 2025, 2:44 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -2.52 | -3.74 | -4.07 | -4.02 | -8.46 | -4.3 | -56.75 |
PS Ratio | n/a | n/a | 1.28K | n/a | n/a | n/a | n/a |
PB Ratio | 2.51 | 0.83 | 1.32 | 6.25 | 8.06 | 3.07 | 33.02 |
P/FCF Ratio | -2.81K | -1.58 | -4.27 | -9 | -10.02 | -6.27 | -71.33 |
P/OCF Ratio | -2.82K | -1.58 | -4.28 | -9.04 | -10.39 | -6.28 | -72.94 |
OCF/S Ratio | n/a | n/a | -299.02 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.07 |
Quick Ratio | 4.36 | 6.27 | 7.53 | 5.93 | 19.19 | 8.26 | 14.06 |
Current Ratio | 4.36 | 6.27 | 7.53 | 5.94 | 20.81 | 11.22 | 14.06 |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | -21.87K | -11.3 | -26.34 |
Return on Equity (ROE) | -1 | -0.22 | -0.32 | -1.56 | -0.95 | -0.71 | -0.58 |
Return on Assets (ROA) | -0.77 | -0.19 | -0.28 | -1.3 | -0.9 | -0.64 | -0.52 |
Return on Capital (ROIC) | -1.05 | -0.96 | -0.6 | -1.54 | -0.92 | -0.33 | -0.52 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 100.00% | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -31.39K% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -40.17K% | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -57.74K% | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | -29.92K% | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -48.81K% | n/a | n/a | n/a | n/a |